Alumis (ALMS) Free Cash Flow (2023 - 2025)
Alumis (ALMS) reported Free Cash Flow of -$71.9 million for Q4 2025, up 4.29% year-over-year from -$68.9 million in Q4 2024, and up 35.17% quarter-over-quarter from -$110.9 million in Q3 2025.
Alumis (ALMS) Free Cash Flow (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Free Cash Flow data on file, last reported at -$71.9 million in Q4 2025.
- Free Cash Flow for Q4 2025 came in at -$71.9 million, up 4.29% year-over-year; the trailing twelve-month figure through Dec 2025 was -$370.2 million (down 44.14% YoY), and the FY2025 annual result was -$370.2 million, down 44.14% from the prior year.
- Free Cash Flow improved to -$71.9 million in Q4 2025 per ALMS's latest filing, from -$110.9 million in the prior quarter.
- Over five years, Free Cash Flow peaked at -$35.0 million in Q4 2023 and troughed at -$110.9 million in Q3 2025.
- A 3-year average of -$69.7 million and a median of -$73.5 million in 2024 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2024 and 2025: Free Cash Flow plunged 139.17% in 2024, then rose 4.29% in 2025.
- A 3-year view of Free Cash Flow shows it stood at -$35.0 million in 2023, then tumbled by 114.75% to -$75.1 million in 2024, then gained by 4.29% to -$71.9 million in 2025.
- Business Quant data shows ALMS's Free Cash Flow at -$71.9 million in Q4 2025, -$110.9 million in Q3 2025, and -$107.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 63,220.27 |
| 10 | Alumis | 1.99 Bn | 1.90 Bn | - | -71.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -71.91 Mn |
| Dec 31, 2025 | -71.91 Mn |
| Sep 30, 2025 | -110.92 Mn |
| Sep 30, 2025 | -110.92 Mn |
| Jun 30, 2025 | -106.96 Mn |
| Jun 30, 2025 | -106.96 Mn |
| Mar 31, 2025 | -80.39 Mn |
| Mar 31, 2025 | -80.39 Mn |
| Dec 31, 2024 | -75.13 Mn |
| Dec 31, 2024 | -75.13 Mn |
| Sep 30, 2024 | -84.59 Mn |
| Sep 30, 2024 | -84.59 Mn |
| Jun 30, 2024 | -52.63 Mn |
| Jun 30, 2024 | -52.63 Mn |
| Mar 31, 2024 | -44.46 Mn |
| Mar 31, 2024 | -44.46 Mn |
| Dec 31, 2023 | -34.99 Mn |
| Dec 31, 2023 | -34.99 Mn |
| Sep 30, 2023 | -35.37 Mn |
| Sep 30, 2023 | -35.37 Mn |